Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of adjuvanted vs non-adjuvanted monovalent H1N1 influenza vaccine in children 3 to <9 years
2014-005106-38Phase 3
- Sponsor
- Novartis
- Start
- Dec 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of monovalent H1N1 influenza virus vaccine in H1N1 influenza (H1N1) (2 arms), sponsored by Novartis. Primary endpoint: Primary immunogenicity endpoints at Day 22, Day 29, and Day 43.
02
Drugs
monovalent H1N1 influenza virus vaccine
03
Conditions
H1N1 influenza (H1N1)
Beyond the preview
Go deeper on 2014-005106-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005106-38.